Vivani Medical, Inc. Common Stock (DE) (VANI) Stock Price

VANIStock

$1.12−24.32%52W

Market Cap$101.03M

P/E—

PEG Ratio—

Div yield—

Beta2.52

VANI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-5.23%

Price vs S&P 500 (4W)-8.35%

VGM Score46.02

Book Value / Share (Quarterly)$0.21

P/TBV (Annual)1.10x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.30

Price vs S&P 500 (YTD)-20.87%

Gross Margin (TTM)36.39%

Net Profit Margin (TTM)-993.79%

EPS (TTM)$-0.36

10-Day Avg Trading Volume0.19M

EPS Excl Extra (TTM)$-0.36

EPS (Annual)$-0.42

ROI (Annual)-130.61%

Gross Margin (Annual)36.39%

Net Profit Margin (5Y Avg)-583.18%

Cash / Share (Quarterly)$0.22

ROA (Last FY)-55.34%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)-151.99%

Operating Margin (TTM)-1004.73%

Cash Flow / Share (Annual)$-0.33

P/B Ratio5.33x

P/B Ratio (Quarterly)5.64x

Net Income / Employee (Annual)$-547,600

Net Interest Coverage (TTM)-4.01x

ROA (TTM)-70.91%

EPS Incl Extra (Annual)$-0.42

Current Ratio (Annual)2.71x

Quick Ratio (Quarterly)3.09x

3-Month Avg Trading Volume0.39M

52-Week Price Return-24.32%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.51

P/S Ratio (Annual)29.89x

Asset Turnover (Annual)0.20x

52-Week High$1.92

Operating Margin (5Y Avg)-586.01%

EPS Excl Extra (Annual)$-0.42

CapEx CAGR (5Y)28.87%

Tangible BV CAGR (5Y)41.24%

26-Week Price Return4.67%

Quick Ratio (Annual)2.56x

13-Week Price Return-15.15%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.25x

Enterprise Value$81.13M

Asset Turnover (TTM)0.12x

Book Value / Share Growth (5Y)-23.27%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)-0.97x

Pretax Margin (Annual)-993.79%

Cash / Share (Annual)$0.21

3-Month Return Std Dev50.39%

Gross Margin (5Y Avg)-2.08%

Net Income / Employee (TTM)$-626,500

ROE (Last FY)-130.61%

Net Interest Coverage (Annual)-0.06x

EPS Basic Excl Extra (Annual)$-0.42

Receivables Turnover (TTM)3.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.36

Receivables Turnover (Annual)7.04x

ROI (TTM)-191.05%

P/S Ratio (TTM)29.89x

Pretax Margin (5Y Avg)-583.18%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.87

Price vs S&P 500 (52W)-39.86%

Year-to-Date Return-8.94%

5-Day Price Return-5.88%

EPS Normalized (Annual)$-0.42

ROA (5Y Avg)-96.95%

Net Profit Margin (Annual)-993.79%

Month-to-Date Return-9.68%

Cash Flow / Share (TTM)$-0.55

EBITD / Share (Annual)$-0.45

Operating Margin (Annual)-1004.44%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-151.99%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.36

P/TBV (Quarterly)1.86x

P/B Ratio (Annual)5.70x

Inventory Turnover (TTM)-0.97x

Pretax Margin (TTM)-993.79%

Book Value / Share (Annual)$0.21

Price vs S&P 500 (13W)-17.84%

Beta2.52x

Revenue / Share (TTM)$0.00

ROE (TTM)-191.05%

52-Week Low$0.92

mGradeC

vgmGradeC

VANI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.08	-$0.07	+16.00%(+$0.01)
Q1 2026	May 13, 2026	-$0.08	-$0.08	+0.00%(+$0.00)
Q4 2025	Mar 26, 2026	-$0.09	-$0.09	+0.00%(+$0.00)
Q3 2025	Nov 13, 2025	-$0.11	-$0.11	+0.00%(+$0.00)
Q2 2025	Aug 13, 2025	-$0.10	-$0.12	-20.00%(-$0.02)

VANI Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

4.10

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About Vivani Medical, Inc. Common Stock (DE)

Vivani Medical is a clinical-stage biopharmaceutical company developing miniature subdermal implants using proprietary NanoPortal technology to deliver medications for chronic diseases with once or twice-yearly dosing. The platform addresses a critical market need by enabling long-term, consistent drug delivery to improve medication adherence. Its flagship candidates focus on GLP-1 delivery, competing in the rapidly growing metabolic disease market alongside established drugs like Ozempic and Wegovy.

VANI Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeAMC

Revenue estimate$0

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

NYXHNyxoah SA Ordinary SharesSurgical & Medical Instruments
SEERSeer, Inc. Class A Common StockLab Analytical Instruments
CODACoda Octopus Group, Inc. Common stockDefense Systems & Equipment
APYXApyx Medical Corporation Common StockSurgical & Medical Instruments
PYPDPolyPid Ltd. Ordinary SharesSurgical & Medical Instruments
KEQUKewaunee Scientific CorpLab Apparatus & Furniture
LUCDLucid Diagnostics Inc. Common StockSurgical & Medical Instruments
LAKELakeland Industries IncOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.92

High$1.92